Top Markets
#1 ADO Protocol ADO Protocol +337.69%
#2 GoPlus Security GoPlus Security +45.51%
#3 Tutorial Tutorial +44.03%
#4 Starpower Starpower +38.64%
#5 The Black Bull The Black Bull +28.94%
#6 Nockchain Nockchain +25.82%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#8 GAIB AID GAIB AID +24.67%
#9 Fake World Assets Fake World Assets +22.34%
#10 OpenEden OpenEden +20.92%
Coin of the day
ADO Protocol ADO Protocol
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Rankning i aktier #34031
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Aktiekurs
$0.5747
Marknadsvärde
$6.42M
Förändring (1 dag)
-23.94%
Förändring (1 år)
-56.79%
Land
US
Handel Citius Pharmaceuticals, Inc. (CTXR)

Kategori

Healthcare
Historik för aktiesplit för Citius Pharmaceuticals, Inc. (CTXR)
Aktien Citius Pharmaceuticals, Inc. (symbol: CTXR) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 17, 2026.
En CTXR-aktie köpt före Aug 17, 2026 motsvarar nu 0 CTXR-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE